IMR Press / EJGO / Volume 28 / Issue 6 / pii/2007211

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Survival rate and prognostic factors for patients who underwent surgical procedures for invasive carcinoma of the vulva in Serbia

Show Less
1 Institute of Gynecology and Obstetrics, Clinical Centre of Serbia, Belgrade, Serbia
Eur. J. Gynaecol. Oncol. 2007, 28(6), 477–479;
Published: 10 December 2007

Objectives: To determine five-year survival rate and prognostic factors for patients who underwent radical surgery for carcinoma of the vulva. Material and Method: 94 women were operated on from 1989 to 1996 at the Clinical Centre of Serbia. Results: Five­year survival was 78.56% for Stage I, 73.5% for Stage II, for Stage III - 14.28%, and for Stage IV - 7.14%. Five-year survival rate for tumor size between 2 cm and 5 cm was 57.14%, and for tumors larger than 5 cm, 28.57%. Five-year survival rate was 64.28% if no lymph nodes were involved, 21.43% if there were unilateral metastatic lymph nodes and 14.28% if bilateral lymph nodes had metastatic disease. Histologic grades of the tumor showed that for grade 1, five-year survival was 64.28%, for grade 2, 35.71 % and there were no survivors five years after surgery among patients with grade 3 tumor. Conclusion: FIGO stage, size of tumor, lymph node involvement and grade of tumor are significant prognostic factors for survival of patients after surgery.

Carcinoma of the vulva
Prognostic factors
Five-year survival rate
Back to top